Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration

Ítems similars

• Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
  per: Naci, Huseyin, et al.
  Publicat: (2017)
• Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020
  per: Zhang, Audrey D., et al.
  Publicat: (2021)
• Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration
  per: Puthumana, Jeremy, et al.
  Publicat: (2021)
• Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
  per: Skydel, Joshua J., et al.
  Publicat: (2019)
• Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation
  per: Puthumana, Jeremy, et al.
  Publicat: (2018)